VMap logo

REVOLUTIONIZING  arrhythmia CARE​

AI-based arrhythmia analysis from just an ECG.

Accurately maps

ATRIAL FIBRILLATION &
SIX OTHER ARRHYTHMIAS

OPTIMIZED

FOR USE IN THE CURRENT PROCEDURAL WORKFLOW

RICH 4-CHAMBER INSIGHTS

FROM NON-INVASIVE,
ECG MAPPING

ADDRESSING A GLOBAL HEALTH CRISIS​

We are advancing care for arrhythmia patients by unlocking insights contained in a standard ECG. vMap is an AI-based arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.

Cardiac arrhythmias cause 10% of global deaths and over 25% of adults over 40 will develop a serious arrhythmia. Untreated arrhythmias not only raise the risk of death but are also associated with serious comorbidities such as stroke and dementia.

A Computer

FDA-INDICATED FOR SEVEN​ ARRHYTHMIAS AND TWO PACING TYPES​

vMap is FDA cleared for use on the following arrhythmias: atrial and ventricular: tachycardia, fibrillation, pacing, premature complexes (PACs and PVCs); and orthodromic atrioventricular reentrant tachycardia. ​

What is vMap? Read More ➞

REFERENCES: ​*Data on file​